title: Does ezetimibe modify clinical outcomes?
authors.affiliation: Pharmacist completing his doctoral training at the University of British Columbia in Vancouver.
authors.forename: Ricky D
authors.initials: RD
authors.lastname: Turgeon
authors.affiliation: Associate Professor of General Internal Medicine at the University of Calgary in Alberta.
authors.forename: Kelly B
authors.initials: KB
authors.lastname: Zarnke
authors.affiliation: Professor and Director of Evidence-Based Medicine in the Department of Family Medicine at the University of Alberta in Edmonton.
authors.forename: G Michael
authors.initials: GM
authors.lastname: Allan
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D008078:Cholesterol, LDL; D004359:Drug Therapy, Combination; D000069438:Ezetimibe / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D000069438:Ezetimibe